$Cerulean Pharma(CERU)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-04-28 AccNo: 0001564590-16-016877 Size: 104 KB 网页链接
公告转发:0回复:0喜欢:0